3-hydroxy-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one
98%
- Product Code: 191749
CAS:
1253056-01-7
| Molecular Weight: | 408.3 g./mol | Molecular Formula: | C₁₆H₁₄F₆N₄O₂ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD30747641 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C |
Product Description:
Used in pharmaceutical research as a key intermediate in the synthesis of potent DPP-4 inhibitors for the treatment of type 2 diabetes. It contributes to the development of antihyperglycemic agents by enhancing the stability and binding affinity of the final drug compound. Its structure supports improved metabolic resistance and target selectivity, making it valuable in optimizing oral glucose-lowering medications.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 G | 10-20 days | ฿28,700.00 |
+
-
|
3-hydroxy-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one
Used in pharmaceutical research as a key intermediate in the synthesis of potent DPP-4 inhibitors for the treatment of type 2 diabetes. It contributes to the development of antihyperglycemic agents by enhancing the stability and binding affinity of the final drug compound. Its structure supports improved metabolic resistance and target selectivity, making it valuable in optimizing oral glucose-lowering medications.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :